AFib ablation slashed progression risk; FDA panel pans empagliflozin for type 1 diabetes
![Daily Medical News show](https://d3dthqtvwic6y7.cloudfront.net/podcast-covers/000/082/495/small/mdedge-daily-news.png)
Summary: AFib ablation slashed progression risk; FDA panel pans empagliflozin for type 1 diabetes
Summary: AFib ablation slashed progression risk; FDA panel pans empagliflozin for type 1 diabetes